Dr. Reddy`s Laboratories Ltd. - ADR (RDY) Company Profile & Statistics

Dr. Reddy`s Laboratories Ltd. - ADR
RDY
(NYSE)
Closed
71.14
+0.23 (+0.32%)
in:usd•As of: Apr 19, 2024 15:59 UTC -4
Open
70.72
High
71.29
Low
70.69

About Dr. Reddy`s Laboratories Ltd. - ADR

CEO

Erez Israeli

Headquarters

8-2-337, road no.3 banjara hills

hyderabad, k7 500-034, india

Auditor

Ernst & Young Associates LLP

Employees

25,863

Share Holders

Website

www.drreddys.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.

Dr. Reddy`s Laboratories Ltd. - ADR Statistics

Valuation Measures

Market Capitalization ²	11.87B
Enterprise Value	12.02B
Enterprise Value/EBITDA (ttm)	12.65
Price to Earnings Ratio (ttm)	18.82
Price to Book (mrq)	3.70
Price to Sales (ttm)	3.62
Price to Cash (ytd)	16.92

Profitability

Gross Margin (ttm)	58.29%
Operating Margin (ttm)	19.26%
Profit Margin (ttm)	19.08%
Return on Equity (ttm)	20.97%
Return on Invested Capital (ttm)	20.12%
Return on Assets (ttm)	15.19%

Income Statement

Revenue (ttm)	3.23B
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	1.89B
EBITDA (ttm)³	950.29M
Net Income Avi to Common (ttm)	621.36M
Diluted EPS (ttm)	3.79

Share Statistics

Beta (5Y Monthly)	0.58
52-Week Change	18.84%
S&P500 52-Week Change	19.56%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.57%
Float ⁴	163.54M
% Held by Insiders	2.00%
% Held by Institutions	14.02%

Balance Sheet

Total Cash (mrq)	877.00M
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	238.00M
Total Debt/Equity (mrq)	7.39%
Current Ratio (mrq)	2.55%
Quick Ratio (mrq)	1.90%
Book Value Per Share (mrq)	19.34

Cash Flow

Operating Cash Flow Per Share (ytd)	2.45
Free Cash Flow (ytd)	286.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Dr. Reddy`s Laboratories Ltd. - ADR

Trade With A Regulated Broker